Novavax (NVAX) Q4 2021 Earnings Report
MX:NVAX Q4 2021 EPS Results
- Actual EPS
- -MXN 210.03
- Consensus EPS
- -MXN 33.85
- Beat/Miss
- Missed by -MXN 176.18
- One Year Ago EPS
- -MXN 50.72
MX:NVAX Q4 2021 Revenue Results
- Actual Revenue
- MXN 4.17B
- Expected Revenue
- MXN 6.23B
- Beat/Miss
- Missed by -MXN 2.06B
- YoY Revenue Growth
- -20.55%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/28/2022
- Time
- After Close
- Conference Call
- Monday, February 28, 2022
MX:NVAX Upcoming Earnings
Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVAX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -6.50- | -23.48 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -7.14-6.01 | 11.65 | -151.61% (-17.66) | |
| May 06, 2026 | 2026 (Q1) | -4.55-1.13 | 55.04 | -102.05% (-56.17) | |
| Feb 26, 2026 | 2025 (Q4) | -9.112.07 | -9.58 | 121.57% (+11.65) | |
| Nov 06, 2025 | 2025 (Q3) | -22.47-23.48 | -14.28 | -64.47% (-9.21) | |
| Aug 06, 2025 | 2025 (Q2) | 0.1511.65 | 18.6 | -37.37% (-6.95) | |
| May 08, 2025 | 2025 (Q1) | -7.9555.04 | -19.73 | 379.05% (+74.77) | |
| Feb 27, 2025 | 2024 (Q4) | -9.66-9.58 | -27.05 | 64.58% (+17.47) | |
| Nov 12, 2024 | 2024 (Q3) | -14.86-14.28 | -23.67 | 39.68% (+9.39) | |
| Aug 08, 2024 | 2024 (Q2) | 31.3718.60 | 10.9 | 70.69% (+7.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed